Heron Therapeutics says chief development officer Forbes buys 50K shares in co

Nov. 20, 2023 11:35 AM ETHeron Therapeutics, Inc. (HRTX)By: Sinchita Mitra, SA News Editor

  • Heron Therapeutics (NASDAQ:HRTX) disclosed that its chief development officer William Forbes bought 50K shares in the company at $0.94 apiece on Nov. 16.
  • Forbes now directly holds 54K shares in the company.
  • In the last three months, net purchase activity was 233.4K shares through insider trading, with two buys and two sales.
  • Shares in the company, up 18.81%.

Recommended For You

More Trending News

See More »

Roy Walsh

Related post